01 — At a Glance
The Health Insurance Middleman That Became A Middleman To Its Own Growth
- 52-Week High / Low₹594 / ₹295
- Q3 FY26 Revenue₹239.68 Cr
- Q3 FY26 PAT₹4.14 Cr
- TTM EPS₹7.92
- Annualised EPS (Q3 Avg × 4)₹1.12
- Book Value / Share₹77.8
- Price to Book4.18x
- PUM (Sep 2025)₹21,108 Cr
- Debt-Free StatusJan 2026
- Promoter Holding4.62%
Flash Summary: Medi Assist is living in three universes simultaneously. Universe 1: Revenue up 28.9% to ₹239.68 crore in Q3, managed ₹21,108 crore of premiums (PUM), and is debt-free. Universe 2: Net profit collapsed 67% in the same quarter because integrating a ₹412 crore acquisition (Paramount TPA) is like inviting a relative to stay “for a few days” who then stays for 18 months. Universe 3: The company’s AI is preventing ₹400 crore in fraud annually, but nobody’s paying for it yet. P/E of 39.4x on a company whose profits are playing hide-and-seek with growth. This is what “scaling” looks like when you’re bad at accounting for it.
02 — Introduction
The Boring Middleman In Healthcare Insurance (Who’s Actually Not Boring)
Imagine you’re an insurance company with 2 crore customers. Now imagine you don’t want to personally call them when they get admitted to a hospital, negotiate with doctors, process their claims, or handle the 100 other things that come with actually managing health insurance. So what do you do? You call Medi Assist. They’re the Third-Party Administrator (TPA) — basically, the hired help of the insurance world.
A TPA is what happens when an insurance company decides complexity is someone else’s problem. Medi Assist runs the whole show: processes 73 lakh claims a quarter, runs a 20,204-hospital network across 141 countries, manages ₹21,108 crore in premiums (PUM), and does it all for 32 insurance companies. They’re in group insurance (32.2% market share), retail insurance (5.6%), and government schemes (serving 33 crore members). It’s like being a hospital coordinator, claims auditor, fraud detective, and customer service representative — all at once, for one company.
They went from being a pure-play TPA to a health-tech company. Along the way, they acquired Medvantage (₹150 cr, Feb 2023), Raksha (₹150 cr, Aug 2023), and Paramount TPA (₹412 crore, July 2025). The idea: consolidate the fragmented TPA industry and become India’s largest. The execution: like a wedding where the caterer forgot half the ingredients but somehow the guests are still eating.
Management on Paramount (Feb 2026 Concall): “The Paramount drag has now come down to a fairly negligible amount at the EBITDA level.” Translation: It was losing ₹6.4% margin in Q2. Now it’s only losing 0.9%. This is what corporate optimism sounds like when you’ve invested ₹412 crore and are waiting for synergies to kick in.
03 — Business Model: What Do TPAs Even Do?
You’re Sick. Insurance Company Doesn’t Want To Deal With You. That’s Where They Come In.
Medi Assist makes money by charging insurance companies a fee to process their customers’ health claims. The company says “this fee is declining” (from 2.98% in FY23 to 2.79% in FY25), which is corporate speak for “we’re in a race to the bottom with competitors.”
They process claims through their subsidiary Medi Assist TPA, which now owns Medvantage TPA and Raksha TPA (post-integration). The revenue mix: 88% TPA, 12% health management/technology. The customer base: 11,000+ corporate clients, 40+ crore individuals across government schemes. The hospital network: 20,204 hospitals. The claims processing scale: 73 lakh claims per quarter, growing 22.4% YoY.
Then there’s the tech play. They built “MAtrix” (their claims platform), “MAven Guard” (AI fraud detection), and “Raksha Prime” (AI-powered cashless discharge). These are being positioned for separate monetization, but currently, it’s feature creep masquerading as diversification. The AI prevented ₹400 crore in fraud YoY (82% identified by AI, not humans), but they’re still figuring out how to charge for this capability. In other words: they’ve built something amazing and are hoping someone pays for it eventually.
Group Market Share32.2%up 307 bps YoY
Premiums Under Mgmt₹21,108 Cr21.9% YoY growth
Claims Processed72.9L9M FY26
Hospital Network20,204across 141 countries
Here’s the irony: Medi Assist is supposed to be India’s largest TPA. But in Feb 2026, they announced a “slump sale” of Paramount TPA into Medi Assist TPA because running two TPAs with one brand is confusing. So they’re merging them. This should have been done in July 2025. They’re doing it in Feb 2026. This is called “operational integration” but sounds more like “we’re still figuring this out.”
04 — Financials Overview
Revenue Goes Up, Profit Goes Down. Somehow, Everyone Cheers.
Result type: Quarterly Results | Q3 FY26 EPS: ₹0.56 | Avg Q1–Q3 EPS: (₹3.18+₹1.13+₹0.56)/3 = ₹1.62 | Annualised EPS: ₹6.48
| Metric (₹ Cr) |
Q3 FY26
Dec 2025 |
Q3 FY25
Dec 2024 |
Q2 FY26
Sep 2025 |
YoY % |
QoQ % |
| Revenue | 239.68 | 185.97 | 232.55 | +28.88% | +3.05% |
| Operating Profit | 44.63 | 39.69 | 39.71 | +12.46% | +12.42% |
| Op Margin % | 18.62% | 21.34% | 17.08% | -272 bps | +154 bps |
| PAT | 4.14 | 29.97 | 8.07 | -66.97% | -48.81% |
| EPS (₹) | 0.56 | 4.19 | 1.13 | -86.63% | -50.44% |
The Plot Twist: Revenue up 28.88% YoY. Operating profit up 12.46%. But PAT down 66.97%. What happened? Paramount happened. Plus interest costs. Plus tax anomalies (they had a -10% tax rate in Q3 FY25 for some reason, so YoY comparisons are broken). Plus amortisation from acquisitions. If you strip out “exceptional items” and one-time costs, management says “underlying PAT” was ₹4.14 crore reported, but really ₹6.04 crore adjusted. This is the definition of “the numbers are confusing but the business is solid.”
💬 When a TPA’s revenue is growing 28.88% but profit is collapsing 67%, are you looking at a company scaling up or a company mismanaging an acquisition? What’s your take?
05 — Valuation Discussion
Paying 39.4x P/E For A Company Whose Profits Are Playing Hide-And-Seek
